Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05649072

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ovarian Cancer Adnexal Diseases Breast Cancer Breast Diseases Breast Neoplasms Colonic Diseases Colorectal Cancer Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Ovarian Diseases Ovarian Neoplasms Rectal Diseases Skin Diseases Skin and Connective Tissue Diseases Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Arun Banu, MD

CONTACT

[email protected]

713-792-2817

Arun Banu, MD

PRINCIPAL_INVESTIGATOR

About this study

Objectives:

  • To identify underserved women at risk for hereditary breast and colorectal cancers and would be eligible for standard of care genetic counseling and testing using national screening guidelines.
  • To provide education to providers and patients regarding hereditary cancers using previously IRB approved educational material and short video.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Exclusion criteria

Treatment and study plan

Genetic Testing and Counseling

Behavioral

Participants will be asked to collect a saliva sample for hereditary cancer and genetic testing

Screening Form

Behavioral

Participant will be answering demographic details

Primary outcomes

  1. To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines.

    Time frame: through study completion; an average of 1 year.

Study contacts

Contact information is provided by the study sponsor or research team.

Arun Banu, MD

CONTACT

[email protected]

(713) 792-2817

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • Community Outreach and Engagement Fund for Underserved Texans

Registry information

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Dec 13, 2022
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.